<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01739855</url>
  </required_header>
  <id_info>
    <org_study_id>Vinforce-015</org_study_id>
    <secondary_id>Vinforce 015</secondary_id>
    <nct_id>NCT01739855</nct_id>
  </id_info>
  <brief_title>Bone Metabolism After Laparoscopic Gastric Bypass Surgery (BABS)</brief_title>
  <acronym>BABS</acronym>
  <official_title>Phase 2 Study of Patients Undergoing Bariatric Surgery (Laparoscopic Gastric Bypass) and Evaluation of Bone Metabolism With/Without Vitamin D/Calcium Supplementation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Medical University of Vienna</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Medical University of Vienna</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Bariatric surgery leads to rapid weight loss in female and male patients. Less data are
      available about its impact on bone metabolism.

      The aim of this study is the investigation of changes in bone mineral density,bone
      histomorphometric changes, serum bone turnover markers and changes in body fat and muscle
      composition in patients after laparoscopic gastric bypass surgery.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Obese female and male adult patients eligible for laparoscopic gastric bypass surgery
      according to the national Austrian guidelines will be included in this study upon request and
      after patient approval.

      Baseline data collection and quarterly follow up visits are planned to investigate the
      changes in bone mineral density and body composition measured by dual energy X-ray
      absorptiometry as well as the evaluation of serum bone turnover markers of bone formation and
      resorption.

      After surgery subjects will be randomized into two groups:

      Daily oral calcium (500mg) and weekly vitamin D3 supplementation (16.000 IU calciferol)or no
      supplementation of calcium and calciferol.

      A sub-study (approximately 15% of study population) with transiliac bone biopsies will also
      be performed to investigate histomorphometric and histologic changes in bone (biopsy baseline
      and after 24 months).

      The planned duration of the study is 24 months for each subject. Serum bone turnover markers
      will be collected every 3 months, dual energy X-ray absorptiometry measurements will be
      performed every 6 months.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>November 2012</start_date>
  <completion_date type="Actual">August 2014</completion_date>
  <primary_completion_date type="Actual">July 2014</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Evaluation of bone mineral density changes in obese patients after laparoscopic bariatric surgery</measure>
    <time_frame>Evaluation every 6 months for 24 months</time_frame>
    <description>Dual energy X-ray absorptiometry (DXA) measurements of bone mineral density at lumbar spine, hip, calcaneus and total body will be performed at baseline and every six months for a period of 24 months.
Differences will be evaluated on the outcome with/without daily calcium (500mg) and weekly vitamin D (16.000 IU calciferol) supplementation</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Evaluation of changes of serum bone turnover markers in obese patients after laparoscopic bariatric surgery</measure>
    <time_frame>Evaluation every 3 months for 24 months</time_frame>
    <description>Fasting serum markers of bone formation and bone resorption will be evaluated:
Calcium, 25-OH-vitamin D3, intact parathyroid hormone, beta-crosslaps, type-1-procollagen, bone specific alkaline phosphatase, osteocalcin, sclerostin, osteoprotegerin, cathepsin-K, fibroblast factor 23, lipoprotein A, dickkopf 1 Differences will be evaluated on the outcome with/without daily calcium (500mg) and weekly vitamin D (16.000 IU calciferol) supplementation</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Evaluation of histomorphometric and histologic changes in obese patients after laparoscopic bariatric surgery</measure>
    <time_frame>baseline and after 24 months</time_frame>
    <description>Transiliac bone biopsies will be performed in a approximately 15% of patients at baseline and after 24 months.
The following parameters will be measured: bone volume (BV/TV), bone surface (BS/BV), osteoblast surface (OS/BS), trabecular number (TbN), trabecular thickness (TbTh, trabecular separation (Tb.sp), mineralized surface (MS/BS), mineral apposition rate (MAR) Differences will be evaluated on the outcome with/without daily calcium (500mg) and weekly vitamin D (16.000 IU colecalciferol) supplementation</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">160</enrollment>
  <condition>Evaluation of Expected Bone Loss After Bariatric Surgery</condition>
  <condition>Possible Prevention of Bone Loss After Surgery by Calcium and Vitamin D Supplementation</condition>
  <arm_group>
    <arm_group_label>Calcium/Vitamin D</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>All subjects will receive calcium/vitamin D supplementation after laparoscopic bariatric gastric bypass surgery as follows:
daily: 500 mg oral calcium (calcium carbonate) weekly: 16.000 IU oral vitamin D3 (calciferol)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>No Calcium/Vitamin D</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>All subjects will not receive calcium/vitamin D supplementation after laparoscopic bariatric gastric bypass surgery.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Calciferol, calcium carbonate</intervention_name>
    <arm_group_label>Calcium/Vitamin D</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  body mass index &gt;35

          -  female and male patients

          -  age 18 - 65 years

          -  eligible for laparoscopic gastric bypass surgery according to the Austrian national
             guidelines

        Exclusion Criteria:

          -  any history of malignancy except basalioma

          -  any prior antiresorptive treatment

          -  any prior calcium or vitamin D supplementation

          -  any secondary disease affecting bone metabolism
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Christian Muschitz, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Medical University Vienna - Austria</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Medical University Vienna</name>
      <address>
        <city>Vienna</city>
        <zip>1060</zip>
        <country>Austria</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Austria</country>
  </location_countries>
  <link>
    <url>http://www.vinforce.at</url>
    <description>Homepage of local research team (in German)</description>
  </link>
  <verification_date>August 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 23, 2012</study_first_submitted>
  <study_first_submitted_qc>November 28, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 4, 2012</study_first_posted>
  <last_update_submitted>August 22, 2014</last_update_submitted>
  <last_update_submitted_qc>August 22, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 25, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Medical University of Vienna</investigator_affiliation>
    <investigator_full_name>Dr. Christian Muschitz</investigator_full_name>
    <investigator_title>Senior Consultant for Internal Medicine</investigator_title>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vitamins</mesh_term>
    <mesh_term>Vitamin D</mesh_term>
    <mesh_term>Ergocalciferols</mesh_term>
    <mesh_term>Cholecalciferol</mesh_term>
    <mesh_term>Calcium, Dietary</mesh_term>
    <mesh_term>Calcium Carbonate</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

